Total Payments
$2,748
2024 Payments
$22.15
Companies
13
Transactions
56
Medicare Patients
1,463
Medicare Billing
$305,971
Payment Breakdown by Category
Food & Beverage$2,635 (95.9%)
Other$105.00 (3.8%)
Education$8.35 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,635 | 53 | 95.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105.00 | 1 | 3.8% |
| Education | $8.35 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $816.16 | 9 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $754.50 | 7 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $456.09 | 15 | $0 (2019) |
| Medtronic, Inc. | $257.34 | 11 | $0 (2023) |
| Novo Nordisk Inc | $140.60 | 2 | $0 (2017) |
| GENZYME CORPORATION | $105.00 | 1 | $0 (2019) |
| AbbVie Inc. | $52.94 | 3 | $0 (2021) |
| Medtronic MiniMed, Inc. | $46.18 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $38.00 | 2 | $0 (2019) |
| Xeris Pharmaceuticals, Inc. | $22.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.15 | 1 | Xeris Pharmaceuticals, Inc. ($22.15) |
| 2023 | $252.48 | 7 | Medtronic, Inc. ($127.48) |
| 2022 | $248.76 | 6 | SANOFI-AVENTIS U.S. LLC ($125.00) |
| 2021 | $347.54 | 6 | SANOFI-AVENTIS U.S. LLC ($250.00) |
| 2020 | $144.05 | 2 | SANOFI-AVENTIS U.S. LLC ($125.00) |
| 2019 | $420.87 | 6 | SANOFI-AVENTIS U.S. LLC ($125.00) |
| 2018 | $503.35 | 7 | Lilly USA, LLC ($245.00) |
| 2017 | $809.04 | 21 | Lilly USA, LLC ($425.01) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/19/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Durable Pump | ||||||
| 12/08/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Durable Pump | ||||||
| 12/08/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Durable Pump | ||||||
| 09/05/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Durable Pump | ||||||
| 06/08/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Durable Pump | ||||||
| 05/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 04/20/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Durable Pump | ||||||
| 12/15/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 12/14/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Nephrology | ||||||
| 10/18/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 09/22/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 07/20/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/02/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 12/10/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/08/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/13/2021 | Medtronic, Inc. | Minimed 770G System (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Durable Pump | ||||||
| 01/21/2021 | Medtronic, Inc. | Minimed 770G System (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Durable Pump | ||||||
| 11/30/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological), TOUJEO | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 07/16/2020 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Durable Pump | ||||||
| 12/12/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Durable Pump | ||||||
| 05/15/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 05/03/2019 | GENZYME CORPORATION | SOLIQUA 100/33 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $105.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 378 | 1,087 | $232,935 | $90,334 |
| 2022 | 5 | 344 | 938 | $205,860 | $76,050 |
| 2021 | 5 | 347 | 954 | $209,575 | $79,544 |
| 2020 | 7 | 394 | 810 | $157,225 | $60,043 |
Total Patients
1,463
Total Services
3,789
Medicare Billing
$305,971
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 572 | $97,240 | $41,255 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 192 | $56,640 | $20,782 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 73 | 78 | $24,960 | $9,174 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 104 | $22,360 | $7,984 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $13,035 | $4,775 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 80 | $12,400 | $4,101 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 28 | $6,300 | $2,263 | 35.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 427 | $72,590 | $28,205 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 203 | $59,885 | $21,452 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 114 | $24,510 | $8,562 | 34.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 61 | $19,520 | $7,756 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 40 | 64 | $9,920 | $3,514 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $9,085 | $3,309 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 46 | $10,350 | $3,252 | 31.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 59 | 491 | $83,470 | $33,148 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 178 | $54,630 | $20,016 | 36.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 62 | 71 | $22,720 | $9,024 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 82 | $17,690 | $5,935 | 33.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $12,555 | $4,557 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 47 | 66 | $10,340 | $3,646 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 35 | $8,170 | $3,217 | 39.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 61 | 337 | $57,290 | $22,767 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 160 | $40,800 | $13,810 | 33.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 61 | 69 | $22,080 | $9,012 | 40.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 74 | $12,580 | $4,542 | 36.1% |
About Dr. Jacob Warman, MD
Dr. Jacob Warman, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144336116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Warman, MD has received a total of $2,748 in payments from pharmaceutical and medical device companies, with $22.15 received in 2024. These payments were reported across 56 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,635).
As a Medicare-enrolled provider, Warman has provided services to 1,463 Medicare beneficiaries, totaling 3,789 services with total Medicare billing of $305,971. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Brooklyn, NY
- Active Since 08/22/2006
- Last Updated 07/09/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1144336116
Products in Payments
- TRULICITY (Drug) $650.01
- SOLIQUA 100/33 (Biological) $375.00
- TOUJEO (Drug) $254.50
- STEGLATRO (Drug) $245.00
- JANUVIA (Drug) $211.09
- MOUNJARO (Drug) $125.00
- TOUJEO (Biological) $125.00
- Tresiba (Drug) $125.00
- MINIMED 780G (Device) $108.83
- SOLIQUA 100/33 (Drug) $105.00
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $81.41
- SYNTHROID (Drug) $49.09
- Minimed 770G System (Device) $48.45
- Minimed 670G System (Device) $46.18
- JARDIANCE (Drug) $38.27
- FARXIGA (Drug) $38.00
- RECORLEV (Drug) $22.15
- TARPEYO (Drug) $21.20
- CRYSVITA (Drug) $20.96
- HUMULIN (Drug) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Brooklyn
Dr. Matin Sharafatkhah, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $437,076
Endocrinology, Diabetes & Metabolism $437,076
Dr. Matvey Brokhin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $373,852
Endocrinology, Diabetes & Metabolism $373,852
Dr. Robert Silver, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $354,536
Endocrinology, Diabetes & Metabolism $354,536
Alexander Perkelvald, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $343,784
Endocrinology, Diabetes & Metabolism $343,784
Dr. Iraklii Buziashvili, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $122,903
Endocrinology, Diabetes & Metabolism $122,903
Dr. Saka Kazeem, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,364
Endocrinology, Diabetes & Metabolism $23,364